Concepedia

Lee Schacter

LS

37

Publications

2.8K

Citations

23

H-Index

1970

Active since

Affiliations

Case Western Reserve University(Current)

Bristol-Myers Squibb (United States)

Bristol-Myers Squibb (Germany)

Cleveland Clinic

Syracuse University

Lee Schacter is an author at Case Western Reserve University specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

1970–2010

37

Publications

37

A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck.

Charlotte Jacobs, Gary H. Lyman, E Vélez-García et al. · Journal of Clinical Oncology · 1992 · 631 citations

Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group.

Bruce J. Roth, David H. Johnson, Lawrence H. Einhorn et al. · Journal of Clinical Oncology · 1992 · 548 citations

Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocol.

Craig R. Nichols, Stephen D. Williams, Patrick J. Loehrer et al. · Journal of Clinical Oncology · 1991 · 288 citations

, , +20

Anagrelide: A New Drug for Treating Thrombocytosis

Murray N. Silverstein, Robert M. Petitt, Lawrence A. Solberg et al. · New England Journal of Medicine · 1988 · 164 citations

, , +14

Etoposide phosphate: what, why, where, and how?

Lee Schacter · PubMed · 1996 · 101 citations

Rows per page

1–5 of 37